Gingivitis comment deadline
This article was originally published in The Tan Sheet
Executive Summary
FDA should extend the deadline for comments on draft guidance for OTC gingivitis drug products from Aug. 29 to Oct. 28, the Consumer Healthcare Products Association requests in a July 15 submission to the agency. The extra 60 days will allow time "to coordinate an industry response and to provide the agency with meaningful and substantive comments," CHPA says. The draft guidance, published June 28, focuses on clinical trials design issues for OTC and Rx gingivitis treatments (1"The Tan Sheet" July 4, 2005, In Brief)...